Sumitomo Receives Approval for world’s first iPS cell‑derived regenerative medicine in Japan
On Mar. 6, 2026, Sumitomo Pharma announce it has obtained conditional and time‑limited approval in Japan for the…
-
-
New stem cell treatment may offer hope for Parkinson’s disease
On Feb. 4, 2026, Keck Medicine of the University of Southern California (USC) announced it is conducting an early phase clinical…
-
Early signs of Parkinson’s can be identified in the blood
On Jan. 29, 2026, a team led by researchers at Chalmers University of Technology and Oslo University Hospital,…
-
New atlas could help researchers studying neurological disease
On Jan. 22, 2026, researchers backed by a Knight Initiative for Brain Resilience Catalyst Momentum Award have laid out…
-
Researchers discover potential new target to treat Parkinson’s disease
On Jan. 15, 2026, a team of Case Western Reserve University researchers announced they have discovered a particular…
-
Biotechnology | Cardiology | Clinical Research | CRISPR | Disease | Non-Profit Research | Oncology | Rare Disease | Therapeutics
CIRM approves over $160M to support preclinical and clinical research, advances education opportunities and access to clinical trials
On Dec. 11, 2025, the California Institute for Regenerative Medicine (CIRM) governing board approved funding of over $160…
-
Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT® for Parkinson’s Disease
On Dec. 5, 2025, Amneal Pharmaceuticals announced new positive interim results from its ongoing Phase 4 ELEVATE-PD study….
-
Scientists unveil the world’s most comprehensive AI-powered tool for neuroscience: Brain Knowledge Platform
On Nov. 12, 2025, Allen Institute researchers and engineers have unlocked an the world’s most comprehensive AI-powered tool…
-
CIRM awards $27 million to launch novel program designed to bring cell and gene therapies to underserved California communities
On Oct. 30, 2025, the California Institute for Regenerative Medicine (CIRM) approved awarding $27 million through three grants…
-
Rice launches Brain Institute to accelerate discoveries in brain science and health
On Oct. 29, 2025, Rice University announced the creation of the Rice Brain Institute (RBI), an ambitious, interdisciplinary…
-
Bath scientists design peptide ‘switch’ that keeps Parkinson’s protein in its healthy form
On Oct. 6, 2025, Researchers at the University of Bath, in collaboration with the Universities of Oxford and…
-
Arrowhead Pharmaceuticals and Novartis Enter into a Global License and Collaboration Agreement
On Sept. 2, 2025, Arrowhead Pharmaceuticals announced a global licensing and collaboration agreement with Novartis for ARO-SNCA, Arrowhead’s…
-
Neural anticipation of virtual infection triggers an immune response
On Jul. 28, 2025, a study published in Nature Neuroscience shows that potential contact with approaching infectious avatars,…
-
Parkinson’s drug effective in treating persistent depression
On Jun. 30, 2025, a University of Oxford led study reported that a drug used for Parkinson’s disease…
-
Scientists solve decades-long Parkinson’s mystery
On Mar. 14, 2025, researchers from the Walter and Eliza Hall Institute of Medical Research (WEHI) announced they…
-
Propranolol reduces tremors in Parkinson’s disease
On Dec. 23, 2024, a study from Radboud University reported that the standard medication levodopa does not always…
-
Large-scale study of brain volume found genetic links to Parkinson’s disease and ADHD
On Oct. 21, 2024, in one of the largest-ever studies of DNA and brain volume, researchers announced they…
-
Biotechnology | Disease | FDA | Neurology | Therapeutics
Amneal Launched CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules for Treatment of Parkinson’s Disease
On Sept. 30, 2024, Amneal Pharmaceuticals announced that it had launched CREXONT ® (carbidopa and levodopa) extended-release capsules…
-
New mutation linked to early-onset Parkinsonism
On Sept. 26. 2024, a team of scientists led by Prof. Patrik Verstreken at the VIB-KU Leuven Center…
-
Study found no link between migraine and Parkinson’s disease
On Aug. 21, 2024, Contrary to previous research, a new study of female participants finds no link between…
-
Biotechnology | Disease | FDA | Neurology | Therapeutics
Amneal Received U.S. FDA Approval for IPX203 for Treatment of Parkinson’s Disease
On Aug. 7, 2024, Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) had approved CREXONT…
-
Biotechnology | Diagnostics | Infectious Disease | Medicine | Neurology | Non-Profit Research | Oncology | Therapeutics
CIRM awarded $53 million to clinical research in heart failure and cystic fibrosis, supporting 10 translational projects
On May 30, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had awarded $53 million to…
-
Findings from 23andMe research on Parkinson’s disease published in Brain
On May 29, 2024, 23andMe with support from The Michael J. Fox Foundation for Parkinson’s Research, announced it…
-
Newly discovered trigger of Parkinson’s upends common beliefs
On Sept. 15, 2023, a Northwestern Medicine study challenges a common belief in what triggers Parkinson’s disease. Degeneration…
-
Milestones in Parkinson’s
Milestones in Parkinson’s illustrates advancements in the disease from James Parkinson’s essay on ‘shaking palsy’ to development of…
-
Parkinson’s disease biomarker found
On Apr. 13, 2023, in an enormous leap forward in the understanding of Parkinson’s disease (PD), researchers announced…
-
Stanford University launched $75 million brain disease initiative
On Apr. 22, 2022, Stanford University announced it was awarded a $75 million gift from Nike co-founder Phil…
-
First-in-human implant of ‘closed-loop’ bioelectronic research system begun for Parkinson’s-like Multiple Systems Atrophy
On Feb. 8, 2022, researchers at Oxford University announced they had implanted a novel closed-loop research platform for…
-
Sanofi and Parkinson’s Foundation collaborated to advance availability of free genetic testing and counseling for people with Parkinson’s disease
On Jun. 1, 2021, Sanofi announced that Vaxelis (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus…
-
Biotechnology | Diagnostics | Disease | Neurology | NIH | Therapeutics
Genetic study of Lewy body dementia supported ties to Alzheimer’s and Parkinson’s diseases
On Feb. 16, 2021, in a study led by National Institutes of Health (NIH) researchers, scientists found that…
